SCHEMBL27367212

SCHEMBL27367212

Cc1ccc(N2CCC(CN3CCC4(CC3)CNC4)CC2)nc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 1/20 0.42
GPR119 Q8TDV5 2/20 0.42
HRH3 Q9Y5N1 2/20 0.38
CHRM4 P08173 2/20 0.38
BPTF Q12830 1/20 0.38
DRD2 P14416 3/20 0.38
DRD1 P21728 3/20 0.38
DRD5 P21918 3/20 0.38
DRD3 P35462 3/20 0.38
HTR1A P08908 1/20 0.38
DRD4 P21917 1/20 0.38
HTR2A P28223 1/20 0.38
HTR2C P28335 1/20 0.38
SLC6A4 P31645 1/20 0.38
HTR7 P34969 1/20 0.38
LCAT P04180 1/20 0.37
GRIN2D O15399 1/20 0.36
GRIN3B O60391 1/20 0.36
GRIN1 Q05586 1/20 0.36
GRIN2A Q12879 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27366337 0.87 PDE10A (0.43) PDE10AGPR119HRH3CHRM4DRD2
SCHEMBL27363571 0.85 GPR119 (0.45) PDE10AGPR119HRH3CHRM4DRD2
SCHEMBL27366423 0.84 HRH3 (0.51) GPR119HRH3BPTFDRD2DRD1
SCHEMBL27366339 0.83 PDE10A (0.47) PDE10AGPR119HRH3CHRM4BPTF
SCHEMBL14853100 0.82 PDE10A (0.48) PDE10AGPR119HRH3CHRM4DRD2
SCHEMBL27363567 0.80 DRD2 (0.47) PDE10AGPR119HRH3CHRM4DRD2
SCHEMBL27363705 0.80 DRD2 (0.47) PDE10AGPR119HRH3CHRM4DRD2
SCHEMBL27362982 0.80 MAPT (0.51) PDE10AGPR119HRH3CHRM4DRD2
SCHEMBL14853102 0.80 DRD2 (0.51) PDE10AGPR119HRH3DRD2DRD1
SCHEMBL27366890 0.79 DRD2 (0.46) PDE10AGPR119HRH3BPTFDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024054591-A1 RAPIDLY ACCELERATED FIBROSARCOMA (RAF) DEGRADING COMPOUNDS AND ASSOCIATED METHODS OF USE ARVINAS OPERATIONS, INC. (US) 2024-03-14 WO disclosed